CNS 파머슈티컬스 (CNSP) 주가

CNS 파머슈티컬스(CNSP)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $5.11 (-0.20%), 시가총액 $7.45M, 52주 범위 $0.75 ~ $10.57.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.

핵심 지표

• 현재가: $5.11 (-0.20%)
• 시가총액: $7.45M
• 52주 최저~최고: $0.75 ~ $10.57
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NAS

CNS 파머슈티컬스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

CNS 파머슈티컬스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 매수 (4.0 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 106.55
• 순이익률: 0.00%
• 영업이익률: 0.00%

자주 묻는 질문